EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
Titel:
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
Auteur:
Davis, I.D. Long, A. Yip, S. Espinoza, D. Thompson, J.F. Kichenadasse, G. Harrison, M. Lowenthal, R.M. Pavlakis, N. Azad, A. Kannourakis, G. Steer, C. Goldstein, D. Shapiro, J. Harvie, R. Jovanovic, L. Hudson, A.L. Nelson, C.C. Stockler, M.R. Martin, A.